Cargando…

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker

Introduction: Systematic pan-cancer analysis of the roles and regulatory mechanisms for PRR7-AS1 is currently not available. Methods: In the present study, a comprehensive bioinformatic approach was used to mine the underlying oncogenic effects of PRR7-AS1, including expression status, prognostic va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rui, Liu, Na, Li, Guiqing, Liu, Jing, Ma, Xiaolin, Liu, Xinling, Li, Jiaqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117660/ https://www.ncbi.nlm.nih.gov/pubmed/37091809 http://dx.doi.org/10.3389/fgene.2023.1160599

Ejemplares similares

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
por: Liu, Shixuan, et al.
Publicado: (2022)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Exploring the oncogenic roles of LINC00857 in pan-cancer
por: Ren, Xiaomin, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E
por: Zhou, Zhixian, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022)

Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis
por: Yu, Yongsheng, et al.
Publicado: (2022)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

A systematic analysis of C5ORF46 in gastrointestinal tumors as a potential prognostic and immunological biomarker
por: Jiang, Yuhong, et al.
Publicado: (2022)

HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer
por: Shen, Qi, et al.
Publicado: (2022)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Super-Enhancer–Associated nine-gene prognostic score model for prediction of survival in chronic lymphocytic leukemia patients
por: Liang, Xue, et al.
Publicado: (2022)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
por: Guo, Xuxue, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
por: Ding, Na, et al.
Publicado: (2023)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Expression analysis of four pseudo-response regulator (PRR) genes in Chrysanthemum morifolium under different photoperiods
por: Wang, Shengji, et al.
Publicado: (2019)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
por: He, Zhibo, et al.
Publicado: (2023)

Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance
por: Cheng, Mei, et al.
Publicado: (2023)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Control of HIV replication by a novel constitutively active ‘super-PRR’
por: Gupta, S, et al.
Publicado: (2012)

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
por: Li, Hetong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5acmi5v4h4d6sp7qvrd040808b